MEDNAX (MD) Misses Q1 EPS by 8c

MEDNAX (NYSE: MD) reported Q1 EPS of $0.75, $0.08 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $835.6 million versus the consensus estimate of $837.34 million.

GUIDANCE:

MEDNAX sees Q2 2017 EPS of $0.85-$0.89, versus the consensus of $1.00.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance